Biotech investors are always looking for companies developing new therapies for tough-to-treat diseases like cancer, but that growth focus almost always puts them at odds with dividend investors, who are more interested in steady and stable growth.
Finding biotech investments that fit the needs of both growth and dividend investors is no easy job. But there are three intriguing companies with ties to biotech that do pay dividends. In the following slide showshow, you'll learn how Amgen (NASDAQ:AMGN), PDL Biopharma (NASDAQ:PDLI), and Teva Pharmaceuticals (NYSE:TEVA) are leveraging biologics for dividend-friendly cash flow.
Todd Campbell has no position in any stocks mentioned. Todd owns E.B. Capital Markets, LLC. E.B. Capital's clients may or may not have positions in the companies mentioned. Todd owns Gundalow Advisors, LLC. Gundalow's clients do not have The Motley Fool recommends Teva Pharmaceutical Industries. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
More from The Motley Fool
Caveat Emptor When Buying High-Yield Drug Stocks
High-yielding pharma and biotech stocks should probably come with a warning label.
Why Transocean, Outfront Media, and PDL BioPharma Jumped Today
Despite a down market, these stocks gained ground. Find out why.
Here's Why PDL BioPharma Inc. Is Soaring Today
Investors are cheering an incredible profit improvement announced Thursday afternoon. But there's a good reason they aren't cheering more loudly.